AMYPAD presents at the 34th annual EANM congress

The 34th Annual EANM congress of the European Association of Nuclear Medicine was held virtually from 20-23 October 2021. It is a world-reference congress in nuclear medicine gathering clinical scientists, technologists, physicians, industry representatives and researchers. With more than 150 sessions, the EANM annual congress is the most valuable Nuclear Medicine Meeting worldwide. Each year, nearly 7,000 participants and 180 companies use the possibility to discuss the newest trends and findings in the field of Nuclear Medicine.

During the event, Lyduine Collij (VUmc) gave a talk entitled “Visual assessment and Centiloid quantification across diagnostic groups: the AMYPAD project”. In this work, Lyduine accessed the distribution in Centiloid units across the two AMYPAD studies, within diagnostic groups (i.e. cognitively unimpaired participants, subjective cognitive decline plus (SCD+), mild cognitive impairment (MCI), and dementia) and to derive the optimal cut-off against visual reads.

If you missed the presentation, the on-demand materials are available on the conference’s platform until 31th December 2021.

The event was very rich and productive. We look forward to continuing the conversations at next year’s EANM in Barcelona (Spain) from 15-19 October, 2022. Save the date!

For more information about EANM 2021, visit


Follow us on Twitter: @IMI_AMYPAD

Receive the latest news. Click here to subscribe!

AMYPAD presents at the 34th annual EANM congress
More News